Physician

Andrew Leo Sochacki, M.D.

According to 2025 Medicare claims, Andrew Sochacki, M.D. (NPI: 1003235391) practices hematology/oncology in the Grand Rapids-Wyoming-Kentwood, MI market, with the plurality of this provider's patient population coming from Kent, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49503-2563. Sochacki is affiliated with the Connected Care of Middle Tennessee, LLC (ACO ID: A3840) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Sochacki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 401 traditional Medicare patients, billed 106,124 HCPCS/CPT codes, and received $1,956,000 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,286 prescription claims across 320 beneficiaries totaling $14,929,204 in drug costs, led by Revlimid (Lenalidomide). DME data shows 11 claims. Open Payments data shows 150 records totaling $550,227. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,595 to $1,956,000. Similarly, Part D prescription costs have moved sharply higher in recent years, from $17,898 to $14,929,204. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	20	24	$1,595
2019	31	35	$1,699
2020	139	12,933	$328,117
2021	422	76,075	$1,257,218
2022	322	60,352	$895,663
2023	335	76,840	$1,032,907
2024	401	106,124	$1,956,000

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	48	359	$17,898
2016	69	616	$31,751
2017	46	355	$46,838
2018	20	33	$83,956
2019	18	37	$133,034
2020	51	166	$285,886
2021	195	1,807	$5,887,574
2022	225	1,787	$7,017,896
2023	220	2,047	$7,962,057
2024	320	3,286	$14,929,204

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	12	$394
2023	N/R	N/R	N/R
2024	N/R	11	$492

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	153	329	$89
80053	Blood test, comprehensive group of blood chemicals	156	830	$10
36415	Insertion of needle into vein for collection of blood sample	156	1,086	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	154	1,076	$8
83615	Lactate dehydrogenase (enzyme) level	133	425	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	181	4,963	$3,241,555
Lenalidomide	Lenalidomide	165	4,613	$2,416,680
Imbruvica	Ibrutinib	116	3,272	$1,718,961
Calquence	Acalabrutinib Maleate	128	3,820	$1,694,684
Venclexta	Venetoclax	108	2,998	$996,210

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	11	$492

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$331	Celgene Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	133	$549,896	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Leo Sochacki, M.D.?

Tedicare shows public-source Medicare data for Andrew Leo Sochacki, M.D. (NPI 1003235391), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Leo Sochacki, M.D. have ACO affiliation data?

Andrew Leo Sochacki, M.D. is shown with ACO affiliation data for Connected Care of Middle Tennessee, LLC (MSSP, ACO ID A3840) and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Andrew Leo Sochacki, M.D.?

Andrew Leo Sochacki, M.D. is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Andrew Leo Sochacki, M.D. have Open Payments data?

Andrew Leo Sochacki, M.D. has 150 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.